Mangrove Partners’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Mangrove Partners’s Portfolio MSACU Stock Details MSACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-150,000	Closed	-$1.48M	–	494
2021 Q1	$1.48M	Buy	+150,000	New	+$1.53M	0.15%	168

Other funds holding MSACU

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Mangrove Partners's MSACU Position: Q2 2021 in Review

Mangrove Partners sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 150,000 shares — an estimated $1.48M sold.

Mangrove Partners first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $1.48M in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

Mangrove Partners reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
Mangrove Partners sold 150,000 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $1.48M.
Mangrove Partners first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
Mangrove Partners's Medicus Sciences Acquisition Corp. Unit position peaked at $1.48M in Q1 2021.
1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Mangrove Partners's 13F filing for Q2 2021, filed 16 Aug 2021.